LitCovid-sentences  

PMC:7536954 / 1304-2473 JSONTXT 9 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T10 0-229 Sentence denotes A 28‐year‐old woman presented with SLE since the age of 13, with renal involvement (class III nephritis), myocarditis, and antiphospholipid antibody syndrome that was previously treated with hydroxychloroquine and salicylic acid.
T11 230-315 Sentence denotes Medical history also included autoimmune thyroiditis, fibromyalgia, and osteoporosis.
T12 316-380 Sentence denotes First manifestations of HS were reported at the age of 20 years.
T13 381-534 Sentence denotes Frequent flares (>2 episodes/months) occurred, and minimal clinical and ultrasonographic improvements were obtained with previous HS‐specific treatments.
T14 535-668 Sentence denotes At our observation (Fig. 1a), the patient reported a worsening of disease associated with a relevant disease burden (Hurley II; IHS4:
T15 669-705 Sentence denotes 12; pain‐Numeric Rating Scale [NRS]:
T16 706-721 Sentence denotes 7/10; itch‐NRS:
T17 722-738 Sentence denotes 3/10; HidraDisk:
T18 739-781 Sentence denotes 62; Dermatology Life Quality Index [DLQI]:
T19 782-786 Sentence denotes 15).
T20 787-963 Sentence denotes Concomitant SLE showed low‐disease activity with current maintenance therapy consisting of hydroxychloroquine (400 mg/day), oral steroids, acetylsalicylic acid, and pregabalin.
T21 964-1169 Sentence denotes Because adalimumab was considered contraindicated, off‐label subcutaneous secukinumab injections at the dosage of 300 mg at weeks 0, 1, 2, 3, and 4, followed by monthly maintenance dosing, were prescribed.